{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:16:51Z","timestamp":1788175011489,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Victorian Department of Justice and Regulation"},{"name":"National Coronial Information System"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.drugalcdep.2019.107556","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T11:21:08Z","timestamp":1568373668000},"page":"107556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-7055","authenticated-orcid":false,"given":"Shane","family":"Darke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Duflou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5946-2144","authenticated-orcid":false,"given":"Julia","family":"Lappin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107556_bib0005","series-title":"Guidance on the Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances","first-page":"335","author":"Abdulrahim","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0010","series-title":"National Drug Strategy Household Survey 2016: Detailed Findings","author":"Australian Institute of Health and Welfare","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.scitotenv.2018.09.348","article-title":"LC-HRMS suspect screening to show spatial patterns of New Psychoactive Substances use in Australia","volume":"650","author":"Bade","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00414-015-1212-4","article-title":"Death following ingestion of methylone","volume":"130","author":"Barrios","year":"2016","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00085030.2012.10757188","article-title":"A case of fatal benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) toxicity","volume":"45","author":"Chatterton","year":"2012","journal-title":"Can. Soc. Forensic Sci. J."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0030","doi-asserted-by":"crossref","first-page":"12863","DOI":"10.1038\/s41598-017-12779-5","article-title":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","volume":"7","author":"Dakic","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0035","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/add.13897","article-title":"Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7 year study","volume":"112","author":"Darke","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0040","series-title":"The Clinician\u2018s Guide To Illicit Drugs And Health","author":"Darke","year":"2019"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jat\/32.2.172","article-title":"Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP","volume":"32","author":"Elliott","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0050","series-title":"European Drug Report 2016: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/15563650.2015.1115056","article-title":"Case series: toxicity from 25B-NBOMe\u2013a cluster of N-bomb cases","volume":"54","author":"Gee","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","volume":"97","author":"German","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0065","series-title":"Drug Misuse: Findings from the 2016\/17 Crime Survey for England and Wales Statistical Bulletin 11\/17","author":"Home Office","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0070","series-title":"SPSS for Windows, 25.0","author":"IBM Inc","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","article-title":"Neurochemical profiles of some novel psychoactive substances","volume":"700","author":"Iversen","year":"2013","journal-title":"Euro. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0080","series-title":"Karch\u2019s Pathology of Drug Abuse","author":"Karch","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuropharm.2017.10.007","article-title":"MDPV and alpha-PVP use in humans: the twisted sisters","volume":"134","author":"Karila","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0090","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/1556-4029.12202","article-title":"Methylenedioxypyrovalerone (\"bath salts\"), related death: case report and review of the literature","volume":"58","author":"Kesha","year":"2013","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0025-6196(12)64946-5","article-title":"Age-related changes in normal human hearts during the first 10 decades of life. Part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old","volume":"63","author":"Kitzman","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jat\/bkw035","article-title":"Detection of 25C-NBOMe in three related cases","volume":"40","author":"Kristofic","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/jat\/bkt058","article-title":"A cluster of deaths involving 5-(2-aminopropyl)indole (5-IT)","volume":"37","author":"Kronstrand","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0110","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.forsciint.2015.02.010","article-title":"25I-NBOMe related death in Australia: a case report","volume":"249","author":"Kueppers","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.forsciint.2016.02.017","article-title":"A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus","volume":"265","author":"Liveri","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jat\/bkx031","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2013\u20132016: a review","volume":"41","author":"Logan","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hup.2423","article-title":"Deaths of individuals aged 16\u201324 years in the UK after using mephedrone","volume":"30","author":"Loi","year":"2015","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/jat\/bkv092","article-title":"A case review of the first analytically confirmed 25I-NBOMe-related death in Washington State","volume":"39","author":"Lowe","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000331007","article-title":"Effectiveness of therapeutic communities: a systematic review","volume":"18","author":"Malivert","year":"2012","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2017.08.028","article-title":"Death after 25C-NBOMe and 25H-NBOMe consumption","volume":"279","author":"Morini","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug \u201cbath salts\u201d containing 3, 4-methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijcard.2013.12.262","article-title":"Sudden death after sustained restraint following self-administration of the designer drug \u03b1-pyrrolidinovalerophenone","volume":"172","author":"Nagai","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2013.12.262","article-title":"Sudden death after sustained restraint following self-administration of the designer drug \u03b1-pyrrolidinovalerophenone","volume":"172","author":"Nagai","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0165","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/bks043","article-title":"Three fatal intoxications due to methylone","volume":"36","author":"Pearson","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0170","series-title":"Opioid-, Amphetamine-, and Cocaine-induced Deaths in Australia","author":"Roxburgh","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0025-6196(12)64945-3","article-title":"Age-related changes in normal human hearts during the first 10 decades of life. Part I (growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old","volume":"63","author":"Scholz","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2016.01.024","article-title":"New psychoactive substance use among regular psychostimulant users in Australia, 2010\u20132015","volume":"161","author":"Sutherland","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0185","doi-asserted-by":"crossref","first-page":"i6848","DOI":"10.1136\/bmj.i6848","article-title":"Novel psychoactive substances: types, mechanisms of action, and effects","volume":"356","author":"Tracy","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0190","series-title":"World Drug Report 2017","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0195","series-title":"Treating Substance Abuse: Theory and Technique","author":"Walters","year":"2012"},{"key":"10.1016\/j.drugalcdep.2019.107556_bib0200","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jat\/34.9.594","article-title":"Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone)","volume":"34","author":"Wikstrom","year":"2010","journal-title":"J. Anal. Toxicol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:01:11Z","timestamp":1759827671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619303333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"alternative-id":["S0376871619303333"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107556","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107556"}}